Presentation TCT 2024 TCT 143: A Validated Risk Model for Acute Kidney Injury Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement Presenter: Charles Odenigbo October 27, 2024
Presentation TCT 2024 Too Good to Be True? Five Top Lessons of Major GLP-1 Agonists Trials Presenter: C. Michael Gibson October 27, 2024
Presentation TCT 2024 How Great if True: My Futuristic View in How GLP-1 Agonist Will Continue Expanding Its Therapeutic Reach Presenter: Marc Bonaca October 27, 2024
Presentation ESC 2024 Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation Presenter: Dipak Kotecha September 01, 2024
Presentation ESC 2024 BedMed and BedMed-Frail randomized controlled trials Presenter: Scott Garrison August 31, 2024
Presentation ESC 2024 QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension Presenter: Stefano Taddei August 31, 2024
Presentation ESC 2024 Continuation versus Interruption of Oral Anticoagulation during TAVI Presenter: Dirk-Jan van Ginkel August 31, 2024
Presentation NY Valves 2024 Real World TTVI Registries: Is There Concordance With the Randomized Trials? Presenter: Bassem M. Chehab June 07, 2024
Presentation NY Valves 2024 Transcatheter Tricuspid Valve Replacement - TRISCEND II Presenter: Raj Makkar June 07, 2024
Presentation NY Valves 2024 Revolutionizing Valvular Disease Diagnosis: Empowering Non-Cardiology Practitioners With AI-Augmented POCUS Presenter: Elad Maor June 05, 2024
Presentation EuroPCR 2024 Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial Presenter: Hans-Josef Feistritzer May 14, 2024
Presentation ACC 2024 PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma? Presenter: David Austin April 08, 2024
Presentation ACC 2024 Evaluation of a Technology Assisted Web Application to Qualify for Nonprescription Statin Administration Presenter: Steven E. Nissen April 08, 2024
Presentation ACC 2024 Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial Presenter: David E. Kandzari April 08, 2024
Presentation ACC 2024 Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC) Presenter: Rasha K. Al-Lamee April 08, 2024
Presentation ACC 2024 Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy Presenter: Eric Quinton Klug April 07, 2024
Presentation ACC 2024 Primary Results from the Phase 2 KARDIA-2 Study Presenter: Akshay Desai April 07, 2024
Presentation ACC 2024 PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques Presenter: Seung-Jung Park April 07, 2024
Presentation ACC 2024 Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial Presenter: Alexander Fanaroff April 07, 2024